| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 30,628 | 27,727 | 28,912 | 31,515 | | Cost of Revenue | 7,752 | 7,800 | 7,712 | 7,885 | | | Gross Profit | 22,876 | 19,927 | 21,200 | 23,630 | | | Operating Expenses | | Research Development | 7,681 | 7,886 | 7,746 | 7,341 | | Selling General and Administrative | 12,992 | 12,665 | 13,938 | 13,457 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,203 | (624) | (484) | 2,832 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 68 | 211 | 265 | | Earnings Before Interest And Taxes | 2,147 | (556) | (273) | 3,097 | | Interest Expense |
-
|
-
| 25 |
-
| | Income Before Tax | 2,147 | (556) | (298) | 3,097 | | Income Tax Expense | 613 | (197) | (227) | 1,135 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,534 | (359) | (71) | 1,962 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,534 | (359) | (71) | 1,962 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,534 | ($359) | ($71) | $1,962 |
|
0.26% Nasdaq 
Income Statement
